Cardiff Oncology CRDF Cash Flow Statement (2011-2026)

NASDAQ CRDF
$0.88 -0.03 (-3.15%)
At close: Aug 21, 2026 · 4:00 PM EDT
1Y3Y5Y7Y10YAll
Download Data
Cash Flow Statement Mar2011 Jun2011 Sep2011 Dec2011 Mar2012 Jun2012 Sep2012 Dec2012 Mar2013 Jun2013 Sep2013 Dec2013 Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Jun2026
Operating Activities
Net Income (Quarter)
-14.33M-14.52M-9.75M-14.75M-13.94M-9.79M-9.57M-12.43M-13.92M-10.17M-48.49M-27.79M-12.91M-14.40M-23.45M-18.15M-18.70M-12.02M-64.48M-9.30M
Depreciation and Depletion (Quarter)
0.10M0.10M0.09M0.09M0.09M0.12M0.09M
Share-based Compensation (Quarter)
1.04M0.94M0.99M1.15M1.05M1.04M1.01M1.06M1.58M0.95M0.91M1.12M1.18M1.25M1.20M1.36M1.68M11.40M1.26M0.92M
Cash from Operations (Quarter)
-4.30M-5.46M-7.39M-10.25M-6.70M-7.49M-9.39M-8.66M-7.13M-7.96M-7.14M-7.74M-9.23M-10.46M-10.27M-12.79M-8.33M-10.83M-5.97M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)
-0.49M-0.46M-0.45M-0.35M-0.21M-0.12M0.04M0.16M0.24M0.31M0.20M0.16M0.13M0.16M0.16M0.14M0.30M0.25M0.16M
Amortization of Deferred Charges (Quarter)
0.13M0.14M0.14M0.14M0.14M0.14M0.14M0.14M
Depreciation & Amortization (CF) (Quarter)
0.11M0.11M0.11M0.03M0.04M0.08M0.09M0.09M0.10M0.11M0.10M0.10M0.10M0.10M0.10M0.09M0.09M0.09M0.09M0.09M
Change in Working Capital
Change in Receivables (Quarter)
0.07M0.09M0.14M-0.09M0.10M0.10M0.12M-0.10M-0.52M0.04M0.09M0.10M0.06M0.17M0.15M-0.37M0.12M-0.27M-0.07M
Change in Accured Expenses (Quarter)
0.02M-0.89M1.55M1.37M-0.04M-1.37M0.20M1.09M0.14M1.40M1.42M0.67M-0.00M0.90M-1.04M4.27M-1.96M0.94M
Other Working Capital Changes (Quarter)
-0.23M-0.18M-0.17M-0.02M-0.13M-0.13M-0.13M-0.14M-0.14M-0.14M-0.15M-0.15M-0.15M-0.16M-0.16M-0.17M-0.17M-0.17M-0.18M
Investing Activities
Capital Expenditures (Quarter)
0.01M0.17M0.31M0.45M-0.70M0.13M0.13M0.32M0.01M0.08M0.90M-0.88M0.02M0.70M
Sales of Property, Plant and Equipment (Quarter)
0.04M
Change in Acquisitions & Divestments (Quarter)
3.01M9.59M13.29M17.09M17.80M26.34M15.22M42.98M25.28M12.27M6.02M5.63M6.87M-2.24M16.84M21.23M-19.99M0.90M
Cash from Investing Activities (Quarter)
-19.00M8.05M-8.79M18.36M7.61M5.16M7.02M7.33M11.48M3.82M13.56M4.64M14.02M-9.43M4.51M-14.58M-4.98M10.16M10.75M
Financing Activities
Other financing activities (Quarter)
-1.26M0.07M0.11M0.25M0.01M0.00M0.03M2.06M
Debt Issuance and Repayment
Long-Term Debt Issuances (Quarter)
Long-Term Debt Repayments (Quarter)
Change in Capital Stock
Shares Issued (Quarter)
6.65M4.43M8.33M0.67M4.43M6.33M6.27M11.79M
Net Equity Issued and Repurchased (Quarter)
19.23M14.96M7.40M44.17M
Misc.
Cash from Financing Activities (Quarter)
19.23M14.96M0.07M0.11M2.06M7.43M44.19M0.00M0.03M2.55M
Exchange Rate Effect (Quarter)
Change in Cash (Quarter)
-4.08M2.58M-1.22M8.11M0.91M-2.25M-2.37M-1.33M4.35M-4.14M6.42M-3.00M6.84M-12.46M38.43M-27.38M-13.31M-0.65M7.33M
Free Cash Flow (Quarter)
-4.30M-5.46M-7.40M-10.42M-7.01M-7.93M-8.69M-8.79M-7.26M-8.27M-7.15M-7.82M-9.23M-10.46M-10.27M-13.70M-7.45M-10.85M-5.97M
Net Cash Flow (Quarter)
-4.08M2.58M-1.22M8.11M0.91M-2.25M-2.37M-1.33M4.35M-4.14M6.42M-3.00M6.84M-12.46M38.43M-27.38M-13.31M-0.65M7.33M